Literature DB >> 24815175

Regulation of macrophage-mediated xenocytotoxicity by overexpression of alpha-2,6-sialyltransferase in swine endothelial cells.

A Maeda1, T Kawamura2, K Nakahata2, T Ueno2, N Usui2, H Eguchi2, S Miyagawa2.   

Abstract

Macrophages play an important role in xenogenic rejection and therefore may represent a major obstacle in clinical application of xenograft. CD33-related sialic acid-binding immunoglobulin-like lectins (Siglecs) belong to the immunoglobulin superfamily and contain a cytoplasmic immunoreceptor tyrosine-based inhibitory motif (ITIM) that is able to inhibit cytokine production. Because human macrophages express various CD33-related Siglecs, we hypothesized that overexpression of α-2,6-sialyltransferase (2,6-ST) in swine endothelial cells (SECs) might prevent the cytotoxicity mediated by macrophages. To confirm our hypothesis, the cytotoxicity of macrophages against 2,6-ST-overexpressing SECs was determined with the use of in vitro-generated macrophages as an effector and naïve or 2,6-ST-overexpressing SECs as a target. The 2,6-ST-overexpressing SECs were established by transfection with the genes for 2,6-ST. Transfection of 2,6-ST led to significant reduction in cytotoxicity compared with naïve SECs. These findings indicate that the sialylated ligands against CD33-related Siglecs may provide an effective therapeutic strategy to inhibit macrophage-mediated xenograft rejection in xenotransplantation.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24815175     DOI: 10.1016/j.transproceed.2013.11.026

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  2 in total

1.  Human CD200 suppresses macrophage-mediated xenogeneic cytotoxicity and phagocytosis.

Authors:  Rieko Sakai; Akira Maeda; Thuy-Vy Choi; Pei-Chi Lo; Patmika Jiaravuthisan; Afifah Mod Shabri; Han-Tang Wang; Rei Matsuura; Tasuku Kodama; Hiroshi Eguchi; Hiroomi Okuyama; Shuji Miyagawa
Journal:  Surg Today       Date:  2017-06-01       Impact factor: 2.549

2.  Suppression of xenogeneic innate immune response by a membrane-type human surfactant protein-A.

Authors:  Chiyoshi Toyama; Akira Maeda; Shuhei Kogata; Riho Yamamoto; Kazunori Masahata; Takehisa Ueno; Masafumi Kamiyama; Yuko Tazuke; Hiroshi Eguchi; Hiroomi Okuyama; Shuji Miyagawa
Journal:  Exp Ther Med       Date:  2022-07-26       Impact factor: 2.751

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.